Opening Asia for Russia

Bahrain first in the world to approve the drug Evusheld against COVID-19

15.11.2021 136 просмотров

The drug will be available to people with weakened immune systems, as well as to citizens and residents of the kingdom, whose professions are associated with the risk of infection.


Bahraini authorities have approved the country's emergency use of the drug Evusheld (also known as AZD7442) manufactured by the British-Swedish company AstraZeneca & nbsp; against COVID-19. This was reported on Sunday by the Bahrain News Agency (BNA).

As specified, the decision was made by the National Health Regulatory Agency after assessing all the necessary data provided by AstraZeneca. The BNA highlights that Bahrain has become the first country to approve the use of this drug against the COVID-19 disease caused by the new coronavirus.

Evusheld, also called the “antibody cocktail”, will be available to people over 18 years of age, mainly for those with weakened immune systems, as well as for citizens and residents of the kingdom, whose professions are associated with the risk of infection.

The medicine is made from a mixture of two monoclonal antibodies - thixagevimab and cilgavimab. The results of its test application showed great effectiveness both in patients with mild symptoms of the disease and in patients with severe cases of coronavirus infection, notes BNA. the development of a severe form of the disease as a result of infection with the SARS-CoV-2 coronavirus. The trials of AZD7442 mainly involved patients at high risk of developing severe COVID-19, including those with comorbidities.

Pandemic situation in Bahrain

In November last year, the Bahraini authorities allowed the use of the Chinese company Sinopharm's drug to vaccinate people who work closely with those infected with coronavirus infection. Later, the kingdom allowed the use of a vaccine produced by the American company Pfizer and its German partner BioNTech, as well as a drug from AstraZeneca. On February 10, the Russian vaccine Sputnik V received permission for use; on February 25, the drug from the American company Johnson & Johnson, and on May 11, Russia's Sputnik Light was approved for emergency use.

The kingdom of 1.7 million people has 245 active cases of COVID-19, 275,563 people have recovered, and 1,393 patients have died from consequences of infection.

The rate of vaccination against coronavirus in Bahrain is considered one of the highest in the world. According to the latest data, 1,183,392 residents of the country received the first dose of the vaccine, 1,147,983 received the second dose, and 491,482 received a booster dose of the drug.

Новости партнёров